Targeted therapy and pharmacogenomic programs
Open Access
- 1 April 2003
- Vol. 97 (S8) , 2076-2082
- https://doi.org/10.1002/cncr.11287
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- cDNA Array Hybridization after Laser-Assisted Microdissection from Nonneoplastic TissueThe American Journal of Pathology, 2002
- Microdissection Is Essential for Gene Expression Profiling of Clinically Resected Cancer TissuesAmerican Journal of Clinical Pathology, 2002
- Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer.International Journal of Colorectal Disease, 2001
- Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapyThe Pharmacogenomics Journal, 2001
- Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5-FluorouracilJapanese Journal of Cancer Research, 2000
- Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trialEuropean Journal Of Cancer, 1995
- Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy.Journal of Clinical Oncology, 1994
- Nucleotide excision repair II: from yeast to mammalsTrends in Genetics, 1993
- Nucleotide excision repair in Escherichia coli.Microbiological Reviews, 1990
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.Journal of Clinical Investigation, 1988